Official government records, as published. No commentary. Every entry links to its source.
Agencies › Federal Register document
2026-07-06 · Notice · Federal Register document 2026-13616

Endo Operations Limited, et al.; Withdrawal of Approval of 34 New Drug Applications

Official abstract: The Food and Drug Administration (FDA or Agency) is withdrawing approval of 34 new drug applications (NDAs) from multiple applicants. The applicants notified the Agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.